XML 63 R44.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Schedule I (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Condensed Financial Statements, Captions [Line Items] |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2025 |  | $ | 4,548 |
2026 |  | 3,756 |
2027 |  | 3,531 |
2028 |  | 3,106 |
2029 |  | 3,656 |
Thereafter |  | 59,908 |
Parent Company [Member] |
Condensed Financial Statements, Captions [Line Items] |
Condensed Balance Sheet [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Balance Sheets
(in millions, except per share data) |  | December 31, 2024 |  | December 31, 2023
Assets |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 234 |  |  | $ | 776 |
Other current assets |  | 411 |  |  | 570 |
Total current assets |  | 645 |  |  | 1,346 |
Equity in net assets of subsidiaries |  | 179,209 |  |  | 153,692 |
Long-term notes receivable from subsidiaries |  | 6,062 |  |  | 5,693 |
Other assets |  | 920 |  |  | 831 |
Total assets |  | $ | 186,836 |  |  | $ | 161,562 |
Liabilities and shareholders’ equity |  |  |  |
Current liabilities: |  |  |  |
Accounts payable and accrued liabilities |  | $ | 1,501 |  |  | $ | 1,116 |
Short-term notes payable to subsidiaries |  | 2,016 |  |  | 9,887 |
Short-term borrowings and current maturities of long-term debt |  | 4,348 |  |  | 4,086 |
Total current liabilities |  | 7,865 |  |  | 15,089 |
Long-term debt, less current maturities |  | 71,831 |  |  | 57,387 |
Long-term notes payable to subsidiaries |  | 14,405 |  |  | — |
Other liabilities |  | 77 |  |  | 330 |
Total liabilities |  | 94,178 |  |  | 72,806 |
Commitments and contingencies (Note 4) |  |  |  |
Shareholders’ equity: |  |  |  |
Preferred stock, $0.001 par value -10 shares authorized; no shares issued or outstanding |  | — |  |  | — |
Common stock, $0.01 par value - 3,000 shares authorized; 915 and 924 issued and outstanding |  | 9 |  |  | 9 |
Retained earnings |  | 96,036 |  |  | 95,774 |
Accumulated other comprehensive loss |  | (3,387) |  |  | (7,027) |
Total UnitedHealth Group shareholders’ equity |  | 92,658 |  |  | 88,756 |
Total liabilities and shareholders’ equity |  | $ | 186,836 |  |  | $ | 161,562 |
Condensed Statement of Comprehensive Income [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Comprehensive Income
|  | For the Years Ended December 31,
(in millions) |  | 2024 |  | 2023 |  | 2022
Revenues: |  |  |  |  |  |
Investment and other income |  | $ | 368 |  |  | $ | 312 |  |  | $ | 255 |
Total revenues |  | 368 |  |  | 312 |  |  | 255 |
Operating costs: |  |  |  |  |  |
Operating costs |  | 108 |  |  | 35 |  |  | 121 |
Interest expense |  | 4,544 |  |  | 3,469 |  |  | 2,110 |
Total operating costs |  | 4,652 |  |  | 3,504 |  |  | 2,231 |
Loss before income taxes |  | (4,284) |  |  | (3,192) |  |  | (1,976) |
Benefit for income taxes |  | 1,032 |  |  | 654 |  |  | 429 |
Loss of parent company |  | (3,252) |  |  | (2,538) |  |  | (1,547) |
Equity in undistributed income of subsidiaries |  | 17,657 |  |  | 24,919 |  |  | 21,667 |
Net earnings |  | 14,405 |  |  | 22,381 |  |  | 20,120 |
Other comprehensive income (loss) |  | 3,640 |  |  | 1,366 |  |  | (3,009) |
Comprehensive income |  | $ | 18,045 |  |  | $ | 23,747 |  |  | $ | 17,111 |
Condensed Cash Flow Statement [Table Text Block] | Condensed Financial Information of Registrant (Parent Company Only) UnitedHealth Group Condensed Statements of Cash Flows
|  | For the Years Ended December 31,
(in millions) |  | 2024 |  | 2023 |  | 2022
Operating activities |  |  |  |  |  |
Cash flows from operating activities |  | $ | 4,852 |  |  | $ | 17,443 |  |  | $ | 14,754 |
Investing activities |  |  |  |  |  |
Issuances of notes to subsidiaries |  | (349) |  |  | (41) |  |  | (567) |
Repayments of notes to subsidiaries |  | 225 |  |  | 817 |  |  | 281 |
Cash paid for acquisitions and other transactions |  | (13,750) |  |  | (8,144) |  |  | (20,728) |
Return of capital to parent company |  | 21 |  |  | 639 |  |  | 1,424 |
Capital contributions to subsidiaries |  | — |  |  | (2,472) |  |  | (570) |
Cash received from dispositions, net |  | 2,444 |  |  | 624 |  |  | 2,787 |
Other, net |  | 30 |  |  | 286 |  |  | — |
Cash flows used for investing activities |  | (11,379) |  |  | (8,291) |  |  | (17,373) |
Financing activities |  |  |  |  |  |
Common stock repurchases |  | (9,000) |  |  | (8,000) |  |  | (7,000) |
Proceeds from common stock issuances |  | 1,846 |  |  | 1,353 |  |  | 1,253 |
Cash dividends paid |  | (7,533) |  |  | (6,761) |  |  | (5,991) |
(Repayments of) proceeds from short-term borrowings, net |  | (151) |  |  | 11 |  |  | 732 |
Proceeds from issuance of long-term debt |  | 17,811 |  |  | 6,394 |  |  | 14,819 |
Repayments of long-term debt |  | (3,000) |  |  | (2,125) |  |  | (3,015) |
(Repayments of) proceeds from short-term notes from subsidiaries, net |  | (7,966) |  |  | 1,188 |  |  | 594 |
Proceeds from long-term notes from subsidiaries |  | 14,396 |  |  | — |  |  | — |
Repayments of long-term notes from subsidiaries |  | (28) |  |  | — |  |  | — |
Other, net |  | (390) |  |  | (702) |  |  | (674) |
Cash flows from (used for) financing activities |  | 5,985 |  |  | (8,642) |  |  | 718 |
(Decrease) increase in cash and cash equivalents |  | (542) |  |  | 510 |  |  | (1,901) |
Cash and cash equivalents, beginning of period |  | 776 |  |  | 266 |  |  | 2,167 |
Cash and cash equivalents, end of period |  | $ | 234 |  |  | $ | 776 |  |  | $ | 266 |
Supplemental cash flow disclosures |  |  |  |  |  |
Cash paid for interest |  | $ | 4,241 |  |  | $ | 3,257 |  |  | $ | 1,969 |
Cash paid for income taxes |  | 2,450 |  |  | 4,426 |  |  | 4,298 |
Schedule of Maturities of Long-term Debt [Table Text Block] | Maturities of short-term borrowings and long-term debt for the years ending December 31 are as follows:
(in millions) |  |
2025 |  | $ | 4,350 |
2026 |  | 3,650 |
2027 |  | 3,425 |
2028 |  | 3,000 |
2029 |  | 3,550 |
Thereafter |  | 59,802 |

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 5 -Subsection 04 -Paragraph c -Subparagraph Schedule I -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 7 -Subsection 05 -Paragraph c -Subparagraph Schedule II -Publisher SEC Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 9 -Subsection 06 -Publisher SEC Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11 + Details
Name: | srt_CondensedFinancialStatementsCaptionsLineItems
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturity and sinking fund requirement for long-term debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1 + Details
Name: | us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |